YALE UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1701-10-09

Employees: 10K

Market Cap: -

Website: http://www.yale.edu

Clinical Trials

Intervention Development for Social Stress, Mental Health, and HIV Risk MSM

Not Applicable

Completed

Conditions: Depression
HIV Infections
Anxiety

Interventions: Behavioral: ESTEEM

First Posted Date: 2015-05-19

Last Posted Date: 2015-05-19

Lead Sponsor: Yale University

Target Recruit Count: 63

Registration Number: NCT02448186

Full-Endoscopic vs Open Discectomy for the Treatment of Symptomatic Lumbar Herniated Disc

Not Applicable

Terminated

Conditions: Lumbar Disc Herniation

Interventions: Procedure: Lumbar discectomy Open
Procedure: Lumbar discectomy Endoscopic

First Posted Date: 2015-05-12

Last Posted Date: 2018-08-07

Lead Sponsor: Yale University

Target Recruit Count: 200

Registration Number: NCT02441959

Locations: 🇺🇸
Yale New Haven Hospital, New Haven, Connecticut, United States

Biological Biomarkers in MOMS Partnership

Terminated

Conditions: Psychological Stress

First Posted Date: 2015-05-08

Last Posted Date: 2020-03-12

Lead Sponsor: Yale University

Target Recruit Count: 20

Registration Number: NCT02438514

Locations: 🇺🇸
Yale University, New Haven, Connecticut, United States

Methionine and PBR28-PET (Peripheral Benzodiazepine Receptors) in Brain Metastases Following Radiosurgery

Terminated

Conditions: Brain Metastasis

Interventions: Procedure: Standard of Care FDG-PET Imaging

First Posted Date: 2015-05-04

Last Posted Date: 2019-05-28

Lead Sponsor: Yale University

Target Recruit Count: 8

Registration Number: NCT02433171

Locations: 🇺🇸
Yale University, New Haven, Connecticut, United States

Improving Reproductive Fitness Through Pretreatment With Lifestyle Modification in Obese Women With Unexplained Infertility

Phase 3

Completed

Conditions: Infertility, Female

Interventions: Other: Caloric Restriction
Drug: Orlistat
Other: Moderate physical activity

First Posted Date: 2015-05-04

Last Posted Date: 2022-02-03

Lead Sponsor: Yale University

Target Recruit Count: 379

Registration Number: NCT02432209

Locations: 🇺🇸
Wayne State University, Southfield, Michigan, United States
🇺🇸
Augusta University, Augusta, Georgia, United States
🇺🇸
University of North Carolina, Chapel Hill, North Carolina, United States

and more 7 locations

Active Surveillance in Prostate Cancer, Imaging to Detect Radiographic Progression as an Endpoint (ASPIRE)

Active, not recruiting

Conditions: Prostate Cancer

First Posted Date: 2015-04-24

Last Posted Date: 2025-01-03

Lead Sponsor: Yale University

Target Recruit Count: 200

Registration Number: NCT02425592

Locations: 🇺🇸
Yale University, New Haven, Connecticut, United States
🇺🇸
VA Connecticut Healthcare System (VACT), West Haven, Connecticut, United States

Males, Antioxidants, and Infertility Trial

Phase 2

Completed

Conditions: Male Infertility

Interventions: Other: Placebo
Drug: Antioxidant Supplement

First Posted Date: 2015-04-21

Last Posted Date: 2019-09-04

Lead Sponsor: Yale University

Target Recruit Count: 171

Registration Number: NCT02421887

Locations: 🇺🇸
University of Oklahoma, Oklahoma City, Oklahoma, United States
🇺🇸
Augusta University, Augusta, Georgia, United States
🇺🇸
University of North Carolina, Chapel Hill, North Carolina, United States

and more 7 locations

Investigation of the Efficacy and Safety of IncobotulinumtoxinA (Xeomin) in Parkinson's Tremor: A Customized Approach

Phase 2

Completed

Conditions: Parkinson
Tremor

Interventions: Drug: incobotulinumtoxinA
Drug: Saline

First Posted Date: 2015-04-17

Last Posted Date: 2016-03-14

Lead Sponsor: Yale University

Target Recruit Count: 33

Registration Number: NCT02419313

Locations: 🇺🇸
Yale Neurology, New Haven, Connecticut, United States

Cannabinoids, Learning, and Memory

Phase 1

Active, not recruiting

Conditions: Cannabis
Psychotic Disorders

Interventions: Drug: THC
Drug: Placebo

First Posted Date: 2015-04-03

Last Posted Date: 2023-10-13

Lead Sponsor: Yale University

Target Recruit Count: 80

Registration Number: NCT02407808

Locations: 🇺🇸
VA Connecticut Healthcare System, West Haven, Connecticut, United States

Evaluating the Combination of MK-3475 and Sterotactic Body Radiotherapy in Patients With Metastatic Melanoma or NSCLC

Phase 1

Completed

Conditions: Melanoma
Lung Cancer

Interventions: Drug: MK-3475
Radiation: Stereotactic Body Radiation Therapy (SBRT)

First Posted Date: 2015-04-02

Last Posted Date: 2023-10-31

Lead Sponsor: Yale University

Target Recruit Count: 61

Registration Number: NCT02407171

Locations: 🇺🇸
Yale Cancer Center, New Haven, Connecticut, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy